
Lindsay Anne Magura Rein
Associate Professor of MedicinePositions
Associate Professor of Medicine in the School of Medicine
2024 School of Medicine
Member of the Duke Cancer Institute in the School of Medicine
2016 School of Medicine
Education
M.D., University of North Dakota, School of Medicine and Health Sciences 2008
2008 University of North Dakota, School of Medicine and Health Sciences
Resident, Duke University, School of Medicine, INTERNAL MEDICINE 2008 - 2011
2011 Duke University, School of Medicine
Clinical Trials
BBI: TP-3654 in Patients with Myelofibrosis
GRN163L vs BAT in MF (Myelofibrosis)
Karyopharm: Phase 1/3 study of selinexor in combo with rux (Myelofibrosis)
Merck-006: Bomedemstat vs BAT for Essential Thrombocythemia
Telios:Phase 2 study of TL-895 (Indolent Systemic Mastocytosis)
Karyopharm:Phase 2 Selinexor monotherapy with JAK inhibitor-naive myelofibrosis and thrombocytopenia
MK-3543 vs Hydroxyurea in Cytoreductive Therapy Naïve Essential Thrombocythemia
Ph 3 Study in MF of Navtemadlin vs Placebo as Add-on Therapy to Rux (Myelofibrosis)
Phase 3 Study of MK-3543 (Thrombocythemia, Polycythemia Vera, and Myelofibrosis)
Publications, Grants & Awards
- Grants (31)
- Academics Articles (33)
- Conference Pages (5)
DCI Centers, Cancer Types & Labs
Offices & Contact
Durham, NC
27710